| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.001 |